Troutman Pepper advised Ganse Apothecary, a Pennsylvania-based closed-door long-term care and specialty pharmacy, in its acquisition by WindRose Health Investors, a New York-based healthcare private equity firm. Read a company press release about the transaction.
Through a merger with existing WindRose portfolio company, Terrapin Pharmacy, the company will create a leading behavioral health pharmacy platform in the Mid-Atlantic. The combination significantly expands the footprint of both businesses and positions the combined organization for growth in existing and new markets, as well as additional lines of businesses and services.
The Troutman Pepper team advising Ganse Apothecary was led by John Jones and John McGrath and included Joseph Harrington, Joan Arnold, Jeremy Frey, Yale Bohn, Kimberly Gillespie, Courtney Goins, Kevin Miserez, Matthew Smith, Austin Marich, Spencer Krantz, Dylan Miller, Kahn Wiedis, Michael Jones, Julia Tomec, Michael Crumbock, Thomas Phelan, and Jessica X.Y. Rothenberg.
Clients with a stake in the health care industry rely on Troutman Pepper to navigate their most important deals and complex issues. From private equity firms and strategics to national health care systems and providers, Troutman Pepper’s clients benefit from the firm’s forward-thinking and efficient approach. The Healthcare Transactions Practice Group, chaired by John Jones, combines its nationally recognized health care private equity, M&A, and transactional capabilities with its health care regulatory and white collar experience to create efficiency in helping clients achieve their optimal outcomes.
Original source can be found here.